Tag: generic drug safety
Learn when pharmacists should flag problematic generic drugs. This guide covers bioequivalence gaps, NTI risks, and practical protocols for ensuring patient safety.
The FDA doesn't stop monitoring generic drugs after approval. Using FAERS, Sentinel, and real-world data, it tracks safety issues, responds to reports, and uses AI to catch problems before they spread. Here's how it works.